News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Brady Todd C
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/11/2023 |
4
| Brady Todd C (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 14,625 options to buy
@ $2.12, valued at
$31k
|
|
| 03/09/2023 |
4
| Brady Todd C (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 15,004 shares
@ $7.12, valued at
$106.8k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
Disposed of 11,000 options to buy
@ $9.05, valued at
$99.6k
Disposed of 10,964 warrants
@ $10.79, valued at
$118.3k
Disposed of 5,500 options to buy
@ $14.27, valued at
$78.5k
Disposed of 5,500 options to buy
@ $13.99, valued at
$76.9k
Disposed of 7,500 options to buy
@ $4.62, valued at
$34.7k
Disposed of 7,500 options to buy
@ $1.6, valued at
$12k
|
|
| 03/02/2023 |
4
| Brady Todd C (President and CEO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 238,750 shares
@ $0
Granted 250,000 options to buy
@ $6.76, valued at
$1.7M
|
|
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2022 |
4
| Brady Todd C (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 57,750 options to buy
@ $0.66, valued at
$38.1k
|
|
| 04/01/2022 |
4
| Brady Todd C (President and CEO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 250,000 shares
@ $0
Granted 250,000 options to buy
@ $4.52, valued at
$1.1M
Granted 207,758 options to buy
@ $0 |
|
| 07/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2020 |
4
| Brady Todd C (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Disposed of 2,741 warrants
@ $43.16, valued at
$118.3k
|
|
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
3
| Brady Todd C (Director) has filed a Form 3 on Avidity Biosciences, Inc. |
| 05/29/2020 |
4
| Brady Todd C (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 57,750 options to buy
@ $2.6, valued at
$150.2k
|
|
| 04/01/2020 |
4
| Brady Todd C (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 13,306 shares
@ $0 |
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2019 |
4
| Brady Todd C (President and CEO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $5.0954, valued at
$101.9k
|
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2019 |
4
| Brady Todd C (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 3,597 shares
@ $0 |
|
| 09/25/2019 |
4
| Brady Todd C (President and CEO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Bought 8,680 shares
@ $5.8102, valued at
$50.4k
|
|
| 09/20/2019 |
4
| Brady Todd C (President and CEO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Bought 14,288 shares
@ $5.9116, valued at
$84.5k
|
|
| 09/17/2019 |
4/A
| Brady Todd C (President and CEO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Bought 18,547 shares
@ $5.8963, valued at
$109.4k
Bought 3,000 shares
@ $6.03, valued at
$18.1k
|
|
| 09/17/2019 |
4
| Brady Todd C (President and CEO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $5.79, valued at
$57.9k
Bought 3,000 shares
@ $6.03, valued at
$18.1k
|
|
| 09/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2019 |
4
| Brady Todd C (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 options to buy
@ $4.62, valued at
$34.7k
|
|
| 07/01/2019 |
4
| Brady Todd C (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 3,354 shares
@ $0 |
|
| 05/03/2019 |
4
| Brady Todd C (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 34,000 options to buy
@ $0.72, valued at
$24.5k
|
|
| 04/02/2019 |
4
| Brady Todd C (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 1,180 shares
@ $0 |
|
| 03/07/2019 |
4
| Brady Todd C (President and CEO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 250,000 shares
@ $0
Granted 250,000 options to buy
@ $8.05, valued at
$2M
Granted 45,329 options to buy
@ $0 |
|
| 06/19/2018 |
4
| Brady Todd C (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 5,500 options to buy
@ $13.99, valued at
$76.9k
|
|
|
|
|